期刊文献+

2-烯丙基-4-羟基-2-环戊烯酮的脂肪酶动力学拆分 被引量:1

Enzymic Kinetic Resolution of 2-Allyl-4-hydroxy-2-cyclopentenone with Lipase
在线阅读 下载PDF
导出
摘要 2-烯丙基-4-羟基-2-环戊烯酮是合成前列腺素PGI1的关键中间体,具有重要的药用价值。该文用改进的方法合成了(±)-2-烯丙基-4-羟基-2-环戊烯酮,总收率27%,用脂肪酶对其进行动力学拆分,得到光学纯的(S)-环戊烯酮醇。结果表明,猪胰脂肪酶具有最佳的拆分效果。以乙酸乙烯酯同时作为溶剂和酰化供体,在25℃,m(酶)∶m(醇)=1.5∶1条件下,环戊烯酮醇的转化率为50.2%,(S)-醇的ee值为58.9%。采用同样条件进行二次酶动力学拆分,得到ee值>98%的手性烯酮醇,总拆分收率23%。 2-Allyl-4-hydroxy-2-eyelopentenone is a key intermediate for the synthesis of prostaglandin PGI1. The racemic 2-allyl-4-hydroxy-2-cyclopentenone was synthesized by an improved method in total yield of 27%. Optical pure (S)- cyclopentenone was obtained by kinetic resolution with lipase. The best resolution performance was shown with porcine pancreas lipase. The enantiomer excess of the cyclopentenone was 58.9% with vinyl acetate as solvent and acyl donator at 25℃ and m( lipase)/m (cyclopentenone) 1.5, while the conversion of cyclopentenone was 50. 2%. The chiral cyclopentenone of 〉 98% enantiomer excess was obtained by a second time enzymic kinetic resolution under the same conditions,and the total yield of the enzymic resolution was 23%.
出处 《精细化工》 EI CAS CSCD 北大核心 2007年第3期290-292,303,共4页 Fine Chemicals
关键词 脂肪酶 拆分 环戊烯酮 前列腺素 lipase resolution cyclopentenone prostaglandin
  • 相关文献

参考文献7

  • 1Clissold D W,Craig S W,Gadikota R R,et al.Prostaglandin synthesis[P].WO:2005/058812,2005-06-30.
  • 2Achab Said,Das Bhupesh C.A concise and general entry into (R)-4-hydroxy-2-substituted cyclopent-2-enones from D-glucose.Chiral intermediates for the synthesis of PGE2,(-)-pentenomycin I,and allethrin[J].J Chem Soc,Perk Trans 1:Org and Bio-Org Chem,1990,(11):2863-2873.
  • 3Masayoshi Minni,Yuji Ueda.Process for preparing optically active 4-hydroxy-2-cyclopentenones[P].US:4 714 782,1987-12-22.
  • 4郭成,曹飞,韦萍,欧阳平凯.工业脂肪酶拆分烯丙酮醇[J].精细化工,2000,17(7):396-397. 被引量:4
  • 5Kevin A Babiak,John S Ng,John H Dygos,et al.Lipase-catalyzed irreversible transesterification using enol esters:resolution of prostaglandin synthons 4-hydroxy-2-alkyl-2-cyclopentenones and inversion of the 4S enantiomer to the 4R enantiomer[J].J Org Chem,1990,55(10):3377-3381.
  • 6Piancatelli G,Scettri A,Barbadoro S.A useful preparation of 4-substituted 5-hydroxy-3-oxocyclopentene[J].Tetrahedron Letters,1976,39:3555-3558.
  • 7Piancatelli G,Scettri A.A simple conversion of 4-substituted 5-hydroxy-3-oxocyclopentenes into the 2-substituted analogs[J].Synthesis,1977,116-117.

二级参考文献6

共引文献3

同被引文献33

  • 1张翀,邢新会.辅酶再生体系的研究进展[J].生物工程学报,2004,20(6):811-816. 被引量:21
  • 2王珺,徐开俊,王礼琛.催化不对称合成法在手性药物合成中的应用[J].药学进展,2005,29(3):106-111. 被引量:7
  • 3王明媚.手性药物的制备方法[J].医药导报,2006,25(4):325-327. 被引量:5
  • 4黄志华,刘铭,王宝光,张延平,曹竹安.甲酸脱氢酶用于辅酶NADH再生的研究进展[J].过程工程学报,2006,6(6):1011-1016. 被引量:26
  • 5Carlos A Martinez, Shanghui H, Yves Dumond, et al. Development of a chemoenzymatic manufacturing process for pregabalin[ J]. Org Process Res Dev,2008,12 ( 3 ) :392 - 398.
  • 6Hoyos P, Hernandez M, Sinisterra J V, et al. Dynamic kinetic resolution of benzoins by lipase-metal combo catalysis [ J ]. Journal of Organic Chemistry,2006,71 (20) :7632 -7637.139.
  • 7Hoyos P, Buthe A, Ansorge-Schurmacher M B, et al. Highly efficient one pot dynamic kinetic resolution of benzoins with entrapped Pseudomonas stutzeri lipase [ J ]. Journal of Molecular Catalysis B : Enzymatic ,2008,52 ( 3 ) : 133 -.
  • 8Dolitzky B Z, Hildesheim J, Finogueev S. Process for producing levetiracetam [ P]. US :7132552B2,2006.
  • 9Pfizer,Hu S,Tao J,et al. Process for producing atorvastatin, pharmaceutically acceptable salts thereof and intermediatest hereof[ P ]. WO : 2006134482,2006.
  • 10Shirae H, Yokozeki K, Kubota K. Enzymic production of ribavirin [ J]. Agric Biol Chem, 1988,52 ( 1 ) :295 - 296.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部